10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
62.65
-0.57 (-0.90%)
At close: Sep 4, 2026, 4:00 PM EDT
62.39
-0.26 (-0.42%)
After-hours: Sep 4, 2026, 7:30 PM EDT
10x Genomics Employees
10x Genomics had 1,178 employees as of December 31, 2025. The number of employees decreased by 128 or -9.80% compared to the previous year.
Employees
1,178
Change (1Y)
-128
Growth (1Y)
-9.80%
Revenue / Employee
$523,694
Profits / Employee
-$63,773
Market Cap
8.16B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,178 | -128 | -9.80% |
| Dec 31, 2024 | 1,306 | 47 | 3.73% |
| Dec 31, 2023 | 1,259 | 16 | 1.29% |
| Dec 31, 2022 | 1,243 | 4 | 0.32% |
| Dec 31, 2021 | 1,239 | 387 | 45.42% |
| Sep 30, 2021 | 1,148 | 435 | 61.01% |
| Jun 30, 2021 | 1,053 | 340 | 47.69% |
| Mar 31, 2021 | 946 | 276 | 41.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 23,500 |
| Veeva Systems | 7,928 |
| Tempus AI | 3,800 |
| Omnicell | 3,485 |
| HealthEquity | 2,814 |
| Waystar Holding | 1,700 |
| Privia Health Group | 1,226 |
| Doximity | 880 |
TXG News
- 5 days ago - 10x Genomics initiated with a Sector Perform at RBC Capital - TheFly
- 8 days ago - 10x Genomics reports patent infringement win against Parse Biosciences - TheFly
- 8 days ago - 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences - PRNewsWire
- 20 days ago - 10x Genomics price target raised to $65 from $50 at Stephens - TheFly
- 27 days ago - 10x Genomics price target raised to $60 from $50 at Canaccord - TheFly
- 27 days ago - 10x Genomics price target raised to $47 from $42 at Piper Sandler - TheFly
- 4 weeks ago - 10x Genomics price target raised to $40 from $37 at Morgan Stanley - TheFly
- 4 weeks ago - 10x Genomics price target raised to $50 from $25 at Stifel - TheFly